As a potent regulator of breast tumor growth and distant metastatic progression, PTHrP has the potential to be leveraged as a therapeutic target for the treatment of breast cancer at multiple stages of disease progression and possibly for the prevention of bone metastasis formation. The gene discussed is PTHLH; the disease is breast carcinoma.